Weight loss jabs could transform public health, unless policy turns them into a luxury |
By Dr. Sophie Dix
The debate surrounding weight loss injections has become one of the most intense and polarised public health discussions in a generation.
These evidence-based, clinically effective medicines, once confined to specialist obesity services, have now entered the mainstream market, fuelled by celebrity endorsements and social media, expanding government access plans, and the undeniable strain on NHS resources.
The stakes are enormous, not just for the pharmaceutical industry, but for the future of British health policy itself.
Ministers rightly see a tantalising prospect: a drug-driven reduction in obesity-related illnesses, easing pressure on hospital waiting lists and boosting national productivity.
Critics, however, argue we are medicalising normal life and sleepwalking into a dangerous “quick-fix” culture that ignores preventative care. But this is not the case.
The truth lies in balancing the........